RVL Pharmaceuticals plc Contract with Customer, Asset, after Allowance for Credit Loss
RVL Pharmaceuticals plc had Contract with Customer, Asset, after Allowance for Credit Loss of $0 as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2023-08-14
- 2023-06-30: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2023-03-31: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2022-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2022-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-14 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-20 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-11 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 |
| 2019-12-31 | $0.00 8-K · filed 2021-09-08 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 8-K · filed 2019-12-20 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |